SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-030955
Filing Date
2023-11-08
Accepted
2023-11-08 16:14:25
Documents
15
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20231107_8k.htm   iXBRL 8-K 24369
2 EXHIBIT 99.1 ex_593215.htm EX-99.1 113584
7 logo01.jpg GRAPHIC 9001
  Complete submission text file 0001437749-23-030955.txt   294797

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrx-20231108.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20231108_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20231108_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20231108_pre.xml EX-101.PRE 11585
9 EXTRACTED XBRL INSTANCE DOCUMENT acrx20231107_8k_htm.xml XML 2572
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 231388022
SIC: 2834 Pharmaceutical Preparations